Immunai
Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.
Domain
immunai.com
Country
United StatesIndustry
AnalyticsEmployees
101-250
Last Funding
$215.0M
Founded
2018
Tech Stack (26 technologies)
Frequently Asked Questions
What technologies does Immunai use?+
Immunai uses 26 technologies including Contact Form 7, Cookiebot, EWWW Image Optimizer.
What industry is Immunai in?+
Immunai operates in the Analytics industry.
Where is Immunai based?+
Immunai is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026